Everett Harris & Co. CA Cuts Stake in Bath & Body Works, Inc. $BBWI

Everett Harris & Co. CA lowered its position in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 32.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 68,585 shares of the company’s stock after selling 33,380 shares during the period. Everett Harris & Co. CA’s holdings in Bath & Body Works were worth $1,377,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Global Retirement Partners LLC purchased a new position in shares of Bath & Body Works during the fourth quarter valued at $31,000. Activest Wealth Management purchased a new position in shares of Bath & Body Works during the fourth quarter valued at $32,000. Geneos Wealth Management Inc. increased its stake in shares of Bath & Body Works by 217.7% during the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after buying an additional 801 shares during the period. Parallel Advisors LLC increased its stake in shares of Bath & Body Works by 42.6% during the fourth quarter. Parallel Advisors LLC now owns 1,897 shares of the company’s stock valued at $38,000 after buying an additional 567 shares during the period. Finally, Danske Bank A S purchased a new position in shares of Bath & Body Works during the third quarter valued at $39,000. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Bath & Body Works Price Performance

BBWI opened at $18.33 on Wednesday. The business’s 50-day moving average is $18.62 and its two-hundred day moving average is $20.03. Bath & Body Works, Inc. has a 1 year low of $14.27 and a 1 year high of $33.96. The firm has a market capitalization of $3.70 billion, a PE ratio of 5.15, a price-to-earnings-growth ratio of 1.82 and a beta of 1.42.

Bath & Body Works (NYSE:BBWI) last posted its earnings results on Wednesday, May 27th. The company reported $0.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.29 by $0.03. Bath & Body Works had a negative return on equity of 45.34% and a net margin of 10.03%.The company had revenue of $1.38 billion for the quarter, compared to analyst estimates of $1.36 billion. During the same quarter in the previous year, the firm earned $0.49 earnings per share. The firm’s quarterly revenue was down 3.2% compared to the same quarter last year. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. As a group, sell-side analysts expect that Bath & Body Works, Inc. will post 2.62 EPS for the current year.

Bath & Body Works Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, June 19th. Shareholders of record on Friday, June 5th will be issued a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 4.4%. The ex-dividend date of this dividend is Friday, June 5th. Bath & Body Works’s dividend payout ratio (DPR) is currently 22.47%.

Analysts Set New Price Targets

Several brokerages have recently commented on BBWI. The Goldman Sachs Group cut their price target on Bath & Body Works from $26.00 to $23.00 and set a “neutral” rating on the stock in a research note on Thursday, May 28th. Piper Sandler initiated coverage on Bath & Body Works in a research note on Friday, May 15th. They issued a “neutral” rating and a $20.00 target price on the stock. Telsey Advisory Group cut their target price on Bath & Body Works from $25.00 to $22.00 and set a “market perform” rating on the stock in a research note on Thursday, May 28th. Citigroup lowered Bath & Body Works from a “buy” rating to a “neutral” rating and lifted their target price for the company from $21.00 to $25.00 in a research note on Tuesday, February 17th. Finally, Barclays cut their target price on Bath & Body Works from $25.00 to $23.00 and set an “equal weight” rating on the stock in a research note on Thursday, May 28th. Three research analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $21.93.

About Bath & Body Works

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.